RNASEL and prostate cancer: Recently, RNASEL has been proposed to be a candidate for HPC1 (Carpten et al, 2002), and a single African American prostate cancer family has been shown to have a mutation in the initiating methionine occurring in four of six brothers with prostate cancer.